Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-04-07
DOI
10.1161/circresaha.120.318556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients
- (2019) Fabian Hammer et al. KIDNEY INTERNATIONAL
- Multi-modality cardiac imaging in advanced chronic kidney disease
- (2019) Carina Ureche et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)
- (2019) Katharina Dörr et al. Trials
- Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts
- (2018) Hyeon Seok Hwang et al. International Journal of Medical Sciences
- Prognostic impact of left ventricular mass change in patients with ST-elevation myocardial infarction
- (2018) Jin-Sun Park et al. MEDICINE
- Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping
- (2018) Marlies Antlanger et al. Scientific Reports
- Fluid status and outcome in patients with heart failure and preserved ejection fraction
- (2017) Benedikt Koell et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hypertension, left ventricular hypertrophy, and sudden cardiac death
- (2017) Mohammad Shenasa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism
- (2017) Geoffrey A. Block et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study
- (2017) Elaine Rutherford et al. Scientific Reports
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM)
- (2015) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism
- (2015) S. M. Sprague et al. Clinical Journal of the American Society of Nephrology
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
- (2015) M. Chonchol et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry
- (2015) Maria Pippias et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
- (2014) Rick A. Nishimura et al. CIRCULATION
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Significance of Interdialytic Weight Gain versus Chronic Volume Overload: Consensus Opinion
- (2013) Manfred Hecking et al. AMERICAN JOURNAL OF NEPHROLOGY
- Increased Left Ventricular Mass as a Predictor of Sudden Cardiac Death
- (2013) Steven M. Stevens et al. Circulation-Arrhythmia and Electrophysiology
- Cinacalcet Improves Endothelial Dysfunction and Cardiac Hypertrophy in Patients on Hemodialysis with Secondary Hyperparathyroidism
- (2013) Sun Ryoung Choi et al. NEPHRON CLINICAL PRACTICE
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
- (2012) Ravi Thadhani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats
- (2011) Soochan Bae et al. CARDIOVASCULAR RESEARCH
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography
- (2011) A. Barbieri et al. European Heart Journal-Cardiovascular Imaging
- Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging
- (2009) R. K. Patel et al. Clinical Journal of the American Society of Nephrology
- Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients
- (2009) Yekaterina GINCHERMAN et al. Hemodialysis International
- Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy
- (2009) S. David et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started